Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

2.83
Data as of Apr 17
 +0.04 / +1.43%
Today’s Change
2.26
Today|||52-Week Range
8.49
-14.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$290.4M

Company Description

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes innovative treatments for infectious diseases. The company is currently engaged in the development of antivirals for the treatment of chronic hepatitis C infection and resistant bacterial infections. Its products include Sovaprevir (ACH-1625), ACH-2684, ACH-2928, ACH-3102, ACH-702 and Elvucitabine. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.

Contact Information

Achillion Pharmaceuticals, Inc.
300 George Street
New Haven Connecticut 06511
P:(203) 624-7000
Investor Relations:
(203) 752-5414

Employees

Shareholders

Individual stakeholders58.81%
Other institutional52.46%
Mutual fund holders30.15%

Top Executives

Milind S. DeshpandePresident, Chief Executive Officer & Director
Mary Kay FentonCFO, Secretary, EVP & Head-Investor Relations
David ApelianChief Medical Officer & Executive Vice President
Kevin KucharskiSenior Vice President-Clinical Operations
Joseph TruittChief Commercial Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.